Cardiogenic shock.
Despite advances in treatment, the mortality rate of patients who develop cardiogenic shock after an acute myocardial infarction remains unacceptably high. This article presents an overview of cardiogenic shock--incidence, epidemiology, predisposing factors, pathophysiology, and management, both medical and surgical.
Josephson
Linda
L
University of Massachusettes Memorial Medical Center, Worcester, MA 01605, USA. Linda@power-guide.com
D002317:Cardiovascular Agents / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D009204:Myocardial Revascularization; D012307:Risk Factors; D012770:Shock, Cardiogenic / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D018746:Systemic Inflammatory Response Syndrome / Q000150:complications
D002317:Cardiovascular Agents